Supporting the Health and Well-being of Children With Intellectual and Developmental Disability During COVID-19 Pandemic

NACompletedINTERVENTIONAL
Enrollment

3,000

Participants

Timeline

Start Date

November 20, 2020

Primary Completion Date

March 29, 2024

Study Completion Date

March 29, 2024

Conditions
Covid19Intellectual DisabilityDevelopmental DisabilityChild Development Disorder
Interventions
BEHAVIORAL

General Communication Message

A messaging strategy will be developed from focus groups that generally describes COVID-19 and the importance of testing.

BEHAVIORAL

Focused/Targeted Message

A messaging strategy that is developed from focus groups that is targeted to address specific concerns of the different communities. Messages may target groups being tested (staff versus students) or sociodemographic or race/ethnicity differences between schools depending on the focus groups input.

BEHAVIORAL

Best Message Alone

The best message will be either the general or focused/targeted message described above.

BEHAVIORAL

Best Message + Augmented Message or Implementation Strategy

The augmented messaging and implementation strategies will be informed by the barriers and facilitators identified based on the CFIR domains and results of focus groups and surveys in Aim 2.

Trial Locations (3)

21205

Hugo W. Moser Research Institute at Kennedy Krieger, Inc., Baltimore

63131

Special School District, St Louis

64110

University of Missouri, Kansas City

All Listed Sponsors
collaborator

Eunice Kennedy Shriver National Institute of Child Health and Human Development (NICHD)

NIH

lead

Washington University School of Medicine

OTHER

NCT04565509 - Supporting the Health and Well-being of Children With Intellectual and Developmental Disability During COVID-19 Pandemic | Biotech Hunter | Biotech Hunter